Redefining Heart Transplant Care – How Donor-Derived Cell-Free DNA is Transforming Rejection Surveillance
6 November, 2025 1:00 p.m. to 2:00 p.m. EST
This webinar will highlight how the innovations of dd-cfDNA and DQS improve detection of rejection, reduce reliance on invasive biopsies, and pave the way for more personalized patient management.
Attendees will gain first-hand insights into how dd-cfDNA testing—enhanced by a two-threshold approach—outperforms traditional surveillance, reduces false positives, and enables earlier, more accurate interventions to protect graft health and improve outcomes.
Watch Session Recording
